Last updated on December 2019

Memory Improvement Through Nicotine Dosing (MIND) Study

Brief description of study

The purpose of the study is to see if daily transdermal nicotine is able to produce a significant cognitive, clinical and functional improvement in participants with MCI. Neuronal nicotinic receptors have long been known to play a critical role in memory function in preclinical studies, with nicotine improving attention, learning, and memory function.

The study will enroll 300 participants for a 2 year period. Participants will be randomized (50:50) to either the transdermal nicotine, beginning at 7mg/day, and increasing to 21mg/day, or placebo skin patch.

Clinical Study Identifier: NCT02720445

Find a site near you

Start Over

Brain Matters Research

Delray Beach, FL United States
  Connect »

JEM Research Institute

Atlantis, FL United States
  Connect »